+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Ankylosing Spondylitis - Global Strategic Business Report - Product Thumbnail Image

Ankylosing Spondylitis - Global Strategic Business Report

  • Report
  • October 2026
  • 271 Pages
  • Global
From
Muscle Relaxant Drugs - Global Strategic Business Report - Product Thumbnail Image

Muscle Relaxant Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 371 Pages
  • Global
From
Aspergillosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 374 Pages
  • Global
From
Hyoscine - Global Strategic Business Report - Product Thumbnail Image

Hyoscine - Global Strategic Business Report

  • Report
  • October 2026
  • 281 Pages
  • Global
From
From
Propolis - Global Strategic Business Report - Product Thumbnail Image

Propolis - Global Strategic Business Report

  • Report
  • October 2026
  • 269 Pages
  • Global
From
Dry Eye Treatment Devices - Global Strategic Business Report - Product Thumbnail Image

Dry Eye Treatment Devices - Global Strategic Business Report

  • Report
  • October 2026
  • 281 Pages
  • Global
From
Artemisinic Acid - Global Strategic Business Report - Product Thumbnail Image

Artemisinic Acid - Global Strategic Business Report

  • Report
  • October 2026
  • 170 Pages
  • Global
From
Paracetamol IV - Global Strategic Business Report - Product Thumbnail Image

Paracetamol IV - Global Strategic Business Report

  • Report
  • October 2026
  • 374 Pages
  • Global
From
Dupuytren`s Disease - Global Strategic Business Report - Product Thumbnail Image

Dupuytren`s Disease - Global Strategic Business Report

  • Report
  • October 2026
  • 369 Pages
  • Global
From
Fungal Keratitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Fungal Keratitis Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 484 Pages
  • Global
From
Skin Antiseptic Products - Global Strategic Business Report - Product Thumbnail Image

Skin Antiseptic Products - Global Strategic Business Report

  • Report
  • October 2026
  • 467 Pages
  • Global
From
From
Edema Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Edema Clinical Trials - Global Strategic Business Report

  • Report
  • October 2026
  • 461 Pages
  • Global
From
From
Respiratory Disease Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Disease Vaccines - Global Strategic Business Report

  • Report
  • October 2026
  • 475 Pages
  • Global
From
Triamcinolone - Global Strategic Business Report - Product Thumbnail Image

Triamcinolone - Global Strategic Business Report

  • Report
  • October 2026
  • 378 Pages
  • Global
From
Typhoid Treatment - Global Strategic Business Report - Product Thumbnail Image

Typhoid Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 366 Pages
  • Global
From
Meningitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Meningitis Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 458 Pages
  • Global
From
Nasal Corticosteroids - Global Strategic Business Report - Product Thumbnail Image

Nasal Corticosteroids - Global Strategic Business Report

  • Report
  • October 2026
  • 469 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more